A 2018 review of 16 scientific studies of cannabis-based mostly medicines for neuropathic discomfort, most of which tested a cannabinoid planning called nabiximols (model title Sativex; a mouth spray containing the two THC and CBD that's authorized in a few nations but not in The us), discovered small- to reasonable-high-quality proof that these me